CJC-1295 vs Tesamorelin: GHRH Research Comparison

CJC-1295 and tesamorelin are both research peptides in the GHRH (growth hormone releasing hormone) analog category. This page compares the two for investigators sourcing material for laboratory research and points to lot documentation and related products.

GHRH-class background

Tesamorelin is described in literature as a GHRH analog; CJC-1295 is described as a modified GHRH analog with extended half-life characteristics in some preparations. Both have been studied in growth hormone axis research models. The two have different pharmacokinetic profiles and are referenced for different study designs.

Research models

Published research on tesamorelin spans visceral adipose and metabolic research models. Published research on CJC-1295 spans growth hormone axis and metabolic research models. Investigators reference the published literature when designing protocols. Amino Fuel Labs makes no therapeutic claims.

Lot documentation

Each lot of tesamorelin and CJC-1295 / ipamorelin is third-party HPLC verified at release. COAs document identity, lot, dates, appearance, and purity, with vial labels matching the COA.

Selecting between them

Researchers select between CJC-1295 and tesamorelin based on study design and the specific receptor and pharmacokinetic profile being investigated. Both are research use only; information here is research peptide information, not medical guidance.